ArticleJournal of medical case reports2026
Autoimmune nodopathy associated with contactin-2 antibodies manifesting as Guillain-Barré syndrome: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe autoimmune nodopathy affecting the node of Ranvier was formerly classified within the spectrum of chronic inflammatory demyelinating polyradiculoneuropathy. However, as a result of comprehensive pathological and immunological investigations conducted in recent years, it has increasingly been recognized as a distinct clinical entity. To date, there have been no reported cases linking autoimmune nodopathy at the node of Ranvier with anti-CNTN2 antibodies. This paper presents a case study demonstrating such an association, detailing the clinical and electrophysiological features, and thereby contributing to the global understanding and recognition of this condition. CASE PRESENTATION: The patient, a 48-year-old female of Han nationality, was admitted to the intensive care unit (ICU) after experiencing a period of unconsciousness, accompanied by a high-grade fever lasting over 4 h. Diagnostic evaluations, including blood tests and imaging studies, indicated the presence of heat stroke and coagulation dysfunction. The therapeutic interventions administered included endotracheal intubation and mechanical ventilation, continuous cooling with electric ice blankets and ice caps, treatments to correct coagulopathy, and aggressive fluid resuscitation. Following these interventions, the patient regained consciousness, and her body temperature returned to normal. However, upon cessation of mechanical ventilation, she exhibited limb weakness and produced indistinct vocalizations, although she was capable of sound production. Routine electromyography identified peripheral nerve injury of the axonal type, while cerebrospinal fluid analysis revealed protein-cell dissociation. Laboratory assays of both blood and cerebrospinal fluid samples tested positive for the anti-CNTN2 antibody IgG. Given the limited availability of effective therapeutic research for this condition at the time, intravenous immunoglobulin therapy was administered with the patient's informed consent, although it did not result in significant improvement of her symptoms.
conclusionClinically, impairments in limb motor abilities, dysarthria, respiratory insufficiency, protein-cell dissociation within the cerebrospinal fluid, and early axonal degeneration as evidenced by electromyography are critical diagnostic criteria for autoimmune nodopathy of the Ranvier nodes in patients who test seropositive for anti-CNTN2 antibodies. For individuals presenting with these phenotypes and suspected of having Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy, it is essential to conduct comprehensive assessments for node, paranode, and juxtaparanode antibodies, along with their specific subtypes, to refine therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.